Related content

Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

By Bax Jeroen   Boogers Mark   Henneman Maureen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 532-534

Springer Publishing Company

Access to resources Recommend Favorite

Standardization of the heart-to-mediastinum ratio of 123 I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations

By Matsuo Shinro  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 560-566

Springer Publishing Company

Access to resources Recommend Favorite

Clinical correlation of the binding potential with ¹²³I-FP-CIT in de novo idiopathic Parkinson’s disease patients

By Berti Valentina   Pupi Alberto   Ramat Silvia   Vanzi Eleonora   Cristofaro Maria   Pellicanò Giannantonio   Mungai Francesco   Marini Paolo   Sorbi Sandro  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 12, 2008-12 ,pp. : 2220-2226

Springer Publishing Company

Access to resources Recommend Favorite

Variations in ¹²³I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

By Verberne Hein   Habraken Jan   Eck-Smit Berthe   Agostini Denis   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite